TONI, Ledjona, Petra DUŠÁTKOVÁ, Dana NOVOTNÁ, Daniela ZEMKOVÁ, Štěpánka PRŮHOVÁ and Jan LEBL. Short stature in a boy with atypical progeria syndrome due to LMNA c.433G > A [p.(Glu145Lys)]: apparent growth hormone deficiency but poor response to growth hormone therapy. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM. BERLIN: WALTER DE GRUYTER GMBH, 2019, vol. 32, No 7, p. 775-779. ISSN 0334-018X. Available from: https://dx.doi.org/10.1515/jpem-2019-0107.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Short stature in a boy with atypical progeria syndrome due to LMNA c.433G > A [p.(Glu145Lys)]: apparent growth hormone deficiency but poor response to growth hormone therapy
Authors TONI, Ledjona (203 Czech Republic, guarantor), Petra DUŠÁTKOVÁ (203 Czech Republic), Dana NOVOTNÁ (203 Czech Republic, belonging to the institution), Daniela ZEMKOVÁ, Štěpánka PRŮHOVÁ and Jan LEBL (203 Czech Republic).
Edition JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, BERLIN, WALTER DE GRUYTER GMBH, 2019, 0334-018X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30209 Paediatrics
Country of publisher Germany
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 1.278
RIV identification code RIV/00216224:14110/19:00110496
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1515/jpem-2019-0107
UT WoS 000474203700016
Keywords in English atypical progeria syndrome; growth hormone deficiency; LMNA
Tags 14110317, rivok
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 26/8/2019 14:19.
Abstract
Background: Hutchinson-Gilford progeria syndrome (HGPS) is a rare disease caused by pathogenic variants in the LMNA gene, which leads to premature aging. The median life expectancy is shortened to 13 years due to cardiovascular complications. Case report: We present a boy born with a pathogenic LMNA variant c.A33G > A, which causes atypical progeria syndrome (APS) and was previously described in one single patient. When investigated for poor growth prior to the diagnosis of APS, his laboratory tests revealed growth hormone (GH) deficiency and magnetic resonance imaging (MRI) of the midbrain showed partial empty sella. Gil treatment had only a limited and transient effect. His first ischemic complication manifested at age 4.2 years; at the age of 7 years, he had a fatal haemorrhagic stroke. Conclusion: To the best of our knowledge, this is the first patient with APS showing partial empty sella and GH deficiency that might have contributed to his poor growth. Gil failed to improve long-term outcome.
PrintDisplayed: 23/7/2024 18:22